{
  "agent": "memo-section-writer",
  "section_id": "A",
  "section_name": "Investment Advisers Act Compliance",
  "status": "COMPLETE",

  "compaction_summary": {
    "task": "Write section IV-A (Investment Advisers Act Compliance) from securities-researcher-report",
    "progress": "COMPLETE - All 6 subsections written",
    "next_action": "Return completion status to orchestrator",
    "critical_context": ["section_id=A", "3 findings analyzed with CREAC", "All quality checks passed"]
  },

  "phases_complete": {
    "phase_1_inputs": true,
    "phase_2_validation": true,
    "phase_3_structure": true,
    "phase_4_analysis": true,
    "phase_5_quality": true,
    "phase_6_finalize": true
  },

  "subsections_status": {
    "A_legal_framework": "complete",
    "B_application": "complete",
    "C_risk_assessment": "complete",
    "D_cross_domain": "complete",
    "E_recommendations": "complete",
    "F_footnotes": "complete"
  },

  "recovery_instructions": {
    "on_compaction": "Section COMPLETE - no recovery needed",
    "do_not_repeat": ["A_legal_framework", "B_application", "C_risk_assessment", "D_cross_domain", "E_recommendations", "F_footnotes"],
    "do_not_reread_reports": ["securities-researcher-report.md", "fact-registry.md", "risk-summary.json"]
  },

  "metrics": {
    "word_count": 10200,
    "findings_written": "3/3",
    "footnotes_count": 162,
    "last_checkpoint": "2026-01-23T02:30:00Z"
  },

  "quality_checks": {
    "word_count_minimum": true,
    "all_subsections_present": true,
    "high_findings_have_contract_language": true,
    "no_placeholders": true,
    "verification_tags_present": true,
    "creac_structure_followed": true,
    "counter_analysis_present": true,
    "no_advocacy_language": true
  },

  "input_files_read": [
    "specialist-reports/securities-researcher-report.md",
    "review-outputs/fact-registry.md",
    "review-outputs/risk-summary.json"
  ],

  "findings_completed": [
    {
      "finding": "SEC October 2023 Examination Deficiencies",
      "severity": "HIGH",
      "exposure": "$7.16M (one-time $1.535M + NPV $5.625M)",
      "contract_language": "Complete (Rep 3.12, Indemnity 8.3, Escrow $3M)",
      "creac_complete": true
    },
    {
      "finding": "Marketing Rule Violations",
      "severity": "MEDIUM",
      "exposure": "$12.435M (penalties $175K + revenue risk $12.26M)",
      "contract_language": "Complete (Rep 3.13, Indemnity 8.4, Escrow $2M)",
      "creac_complete": true
    },
    {
      "finding": "Revenue Sharing Fiduciary Conflicts",
      "severity": "MEDIUM",
      "exposure": "$12.9M (annual revenue at risk)",
      "contract_language": "Complete (Rep 3.14, Indemnity 8.5, Pre-closing condition)",
      "creac_complete": true
    }
  ],

  "output_file": "/Users/ej/Super-Legal/super-legal-mcp-refactored/reports/2026-01-22-1737576000/section-reports/section-IV-A-investment-advisers-act.md"
}
